Joint Corp reports results for the quarter ended June 30 - Earnings Summary
Joint Corp reports results for the quarter ended June 30 - Earnings Summary
Joint Corp JYNT.OQ reported a quarterly adjusted loss of 1 cent per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of four analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from -2 cents to 9 cents per share.
Revenue rose 14.4% to $15.18 million from a year ago; analysts expected $14.57 million.
Joint Corp's reported EPS for the quarter was 5 cents.
The company reported quarterly net income of $653 thousand.
Joint Corp shares had fallen by 5.1% this quarter and lost 4.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 40% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Joint Corp is $9.00, about 7.4% above its last closing price of $8.33
This summary was machine generated from LSEG data August 6 at 09:49 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.05 | -0.01 | Missed |
Mar. 31 2026 | 0.03 | 0.08 | Beat |
Dec. 31 2025 | 0.04 | 0.07 | Beat |
Sep. 30 2025 | 0.00 | 0.02 | Beat |
Recent news on Joint
See all newsBrief: Joint Corp To Reacquire Texas Regional Development Rights And Terminate Related Agreements
Brief: Joint Corp. To Close Underperforming Clinics In 2026
Joint Corp reports results for the quarter ended June 30 - Earnings Summary
The Joint Corp Q2 revenue beats estimates, reiterates 2026 outlook
Brief: Joint Q2 EPS USD 0.05